Get past the panel — and in front of the people who matter.
Reach the buyers most agencies can't — in the publications they read, with claims that hold up.
We help commercial leaders in life sciences, medtech, and other regulated markets put their message in front of a specialized, skeptical audience — in the publications those buyers already trust — with targeting and creative built to earn real attention and move through MLR or promotional review.
Interested in learning more?
View our library of testimonials, or book your first strategy session on the house.
You want ads that reach a careful, regulated audience…
…but most media plans buy impressions and hope the right people notice.
You need to show up where the skeptics learn.
You want your buyers — the scientists, clinicians, and technical evaluators who actually influence the purchase — to see a credible message in a place they already trust, and to take it seriously enough to act.
You need to show up where the skeptics learn.
You want your buyers — the scientists, clinicians, and technical evaluators who actually influence the purchase — to see a credible message in a place they already trust, and to take it seriously enough to act.
You need to show up where the skeptics learn.
You want your buyers — the scientists, clinicians, and technical evaluators who actually influence the purchase — to see a credible message in a place they already trust, and to take it seriously enough to act.
But the usual media plan doesn't reach them.
Your audience is small, specific, and hard to buy. Broad programmatic and generic B2B channels spend most of the budget reaching people who will never buy. The people who do matter are careful readers who ignore anything that looks like an ad and reads like hype. Attention gets faked elsewhere with bait and bots, and this audience sees through it — so the numbers look fine while nothing moves.
But the usual media plan doesn't reach them.
Your audience is small, specific, and hard to buy. Broad programmatic and generic B2B channels spend most of the budget reaching people who will never buy. The people who do matter are careful readers who ignore anything that looks like an ad and reads like hype. Attention gets faked elsewhere with bait and bots, and this audience sees through it — so the numbers look fine while nothing moves.
But the usual media plan doesn't reach them.
Your audience is small, specific, and hard to buy. Broad programmatic and generic B2B channels spend most of the budget reaching people who will never buy. The people who do matter are careful readers who ignore anything that looks like an ad and reads like hype. Attention gets faked elsewhere with bait and bots, and this audience sees through it — so the numbers look fine while nothing moves.
More impressions won't fix a reach problem.
When your budget buys volume instead of the right rooms, the cost of reaching an actual buyer climbs, the campaign looks busy in the dashboard, and your brand shows up next to content that erodes the credibility you need most. Buying more of the same doesn't get you closer to a specialized audience — it just spends faster. The gap is where you show up and whether the message earns a careful reader's attention, not how many impressions you can rent.
More impressions won't fix a reach problem.
When your budget buys volume instead of the right rooms, the cost of reaching an actual buyer climbs, the campaign looks busy in the dashboard, and your brand shows up next to content that erodes the credibility you need most. Buying more of the same doesn't get you closer to a specialized audience — it just spends faster. The gap is where you show up and whether the message earns a careful reader's attention, not how many impressions you can rent.
More impressions won't fix a reach problem.
When your budget buys volume instead of the right rooms, the cost of reaching an actual buyer climbs, the campaign looks busy in the dashboard, and your brand shows up next to content that erodes the credibility you need most. Buying more of the same doesn't get you closer to a specialized audience — it just spends faster. The gap is where you show up and whether the message earns a careful reader's attention, not how many impressions you can rent.
With MESH, the right buyers see you in a place they trust — and take seriously.
Your message reaches the specialties that matter, in publications your audience reads for credible information, so it arrives with borrowed trust instead of fighting for it. Claims are built to hold up, so campaigns move through review instead of dying in it. And because the creative earns attention on its merits, the response you get is real — from people who could actually buy.
With MESH, the right buyers see you in a place they trust — and take seriously.
Your message reaches the specialties that matter, in publications your audience reads for credible information, so it arrives with borrowed trust instead of fighting for it. Claims are built to hold up, so campaigns move through review instead of dying in it. And because the creative earns attention on its merits, the response you get is real — from people who could actually buy.
With MESH, the right buyers see you in a place they trust — and take seriously.
Your message reaches the specialties that matter, in publications your audience reads for credible information, so it arrives with borrowed trust instead of fighting for it. Claims are built to hold up, so campaigns move through review instead of dying in it. And because the creative earns attention on its merits, the response you get is real — from people who could actually buy.
Trusted for growth by leaders of highly regulated companies
Trusted for growth by leaders of highly regulated companies
Trusted for growth by leaders of highly regulated companies
We reach specialized regulated audiences that generic media plans miss — in the industry publications those buyers already read — through agency-level access to premium placements and targeting most teams don’t even know exists.
Then we build the creative and the offer to earn a careful reader's attention and to move through MLR or promotional review, so the campaign reaches the right people, holds up under scrutiny, and produces a response you can trust.
Different by design.
We place where most agencies don’t.
Agency-level access to premium, specialty-level inventory means your budget reaches a targeted, credible audience instead of the open generic market.
We place where most agencies don’t.
Agency-level access to premium, specialty-level inventory means your budget reaches a targeted, credible audience instead of the open generic market.
We build claims to survive review, not to skirt it.
Positioning and substantiation are shaped to move through MLR and promotional review, so campaigns launch on time and hold up under scrutiny.
We build claims to survive review, not to skirt it.
Positioning and substantiation are shaped to move through MLR and promotional review, so campaigns launch on time and hold up under scrutiny.
We build for a reader who punishes hype.
The people who decide in these markets are scientists, clinicians, and engineers — so the creative earns attention on substance, and the response you get is real.
We build for a reader who punishes hype.
The people who decide in these markets are scientists, clinicians, and engineers — so the creative earns attention on substance, and the response you get is real.
Senior-led, and the strategy comes with the means to run it.
The people who scope your media plan run it — backed by expert creative and AI — so you get placement, creative, and measurement connected, not a handoff to three vendors.
Senior-led, and the strategy comes with the means to run it.
The people who scope your media plan run it — backed by expert creative and AI — so you get placement, creative, and measurement connected, not a handoff to three vendors.
Case studies.
See for yourself how we've helped companies like yours scale.
Channel Partner Case Study: Building Distributor Support Without Losing the Brand
Channel Partner Case Study: Building Distributor Support Without Losing the Brand
Channel Partner Case Study: Building Distributor Support Without Losing the Brand
ABM Case Study: Small Med Device Distributor Growth
ABM Case Study: Small Med Device Distributor Growth
ABM Case Study: Small Med Device Distributor Growth
Content Marketing Case Study: Driving Leads Through with Customer-Centric Strategy
Content Marketing Case Study: Driving Leads Through with Customer-Centric Strategy
Content Marketing Case Study: Driving Leads Through with Customer-Centric Strategy
Content Case Study: Increased Qualified Sales Leads Through Persona-Driven Strategy
Content Case Study: Increased Qualified Sales Leads Through Persona-Driven Strategy
Content Case Study: Increased Qualified Sales Leads Through Persona-Driven Strategy
Growth Case Study: Branding and Marketing Positions European Chip Maker as a Leader in IoT
Growth Case Study: Branding and Marketing Positions European Chip Maker as a Leader in IoT
Growth Case Study: Branding and Marketing Positions European Chip Maker as a Leader in IoT
Demand Generation Case Study: DentalCo Jump-Start Campaign to Rebuild US Demand
Demand Generation Case Study: DentalCo Jump-Start Campaign to Rebuild US Demand
Demand Generation Case Study: DentalCo Jump-Start Campaign to Rebuild US Demand
Ready to reach the audience most media plans miss?
If your message isn't reaching the specialties that matter — or it's reaching them and not landing — let's look at where your buyers actually read and what it would take to show up there credibly.
Latest articles and publications.
Learn something new and get a glimpse inside how we think.
Why isn't our company growing as quickly as we expected?
Written by
Bill Schick
How do we turn a breakthrough idea into a successful commercial product?
Written by
Bill Schick
How do I know if the market will actually adopt what we're building?
Written by
Bill Schick
Your Buyers Aren’t Clicking Anymore: How AEO Changes the First 30% of the Sales Cycle
Written by
Bill Schick
Life Science Long Tail Keyword Guide to Driving Conversions
Written by
Bill Schick
Keyword Research for Life Sciences: The Most Effective Approaches for 2026
Written by
Bill Schick
Why isn't our company growing as quickly as we expected?
Written by
Bill Schick
How do we turn a breakthrough idea into a successful commercial product?
Written by
Bill Schick
How do I know if the market will actually adopt what we're building?
Written by
Bill Schick
Your Buyers Aren’t Clicking Anymore: How AEO Changes the First 30% of the Sales Cycle
Written by
Bill Schick
Publication advertising FAQs.
How do you decide where to place our ads and what they should say?
How is this different from what our own team or a generic agency would run?
Why does real attention matter more than impressions for this audience?
What is publication advertising for regulated markets?
Which publications and audiences can you reach?
How do you keep the ads compliant with MLR and promotional review?
Do you handle the creative, or only the placement?
How do we know it's working?
How quickly can we get into market?